News | July 14, 2025
The former NBPA Executive Director, based in Washington, DC, will lead Secretariat’s growing Global Sports Consulting capabilities.
Launch-at-Risk Analysis for Generic Pharmaceutical Company
Background
Secretariat worked with a generic pharmaceutical company to evaluate potential risks and rewards in an “launch-at-risk” generic drug. Secretariat’s complex, scenario-based modeling provided key insights and drove economically informed decision making.
Latest Insights
News | July 9, 2025
Why Funder Forecasts Don’t Belong in Royalty Analysis
In a recent article published by Law360, Managing Director Rick Eichmann explores the economic reasoning behind the U.S. District Court’s decision in Haptic Inc. v. Apple Inc. and why prelitigation funding forecasts should not be conflated with royalty analyses in patent litigation.
Article | July 9, 2025
SFO’s ‘Cast-Iron Guarantee’ on Self-Reporting Comes With Fine Print
Ben Boorer, writing for Corporate Compliance Insights, examines the UK Serious Fraud Office’s clearest commitment yet to corporate self-reporting, offering a “cast-iron guarantee” of DPA negotiations for companies that self-report and cooperate.